ClinConnect ClinConnect Logo
Search / Trial NCT04179292

The Effect of Physiotherapy Program in Scleroderma Patients

Launched by ISTANBUL UNIVERSITY · Nov 26, 2019

Trial Information

Current as of July 21, 2025

Completed

Keywords

Scleroderma Systemic Sclerosis Hand Therapy

ClinConnect Summary

Scleroderma is an autoimmune connective tissue disease with fibrosis. Although its etiology and pathogenesis have not been clearly defined, it has a chronic course. It is estimated that scleroderma affects approximately 300,000 people in the United States. Most commonly, it affects adults and women.

When the current literature is examined, Landim et al. in their studies for the development and evaluation of hand exercises home program in patients with systemic scleroderma; They found that the 8-week home exercise program had positive effects on pain, function, mobility and strength. Antoni...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Having been diagnosed with scleroderma
  • Stability of medical treatments
  • To be able to adapt to the exercises
  • Exclusion Criteria:
  • The patient has a history of neurological disease or trauma that may affect his symptoms
  • Systemic involvement that affects the treatment process
  • Being in the active phase of the disease

About Istanbul University

Istanbul University, a leading institution in Turkey, is dedicated to advancing healthcare through rigorous clinical research and education. Renowned for its commitment to scientific excellence and innovation, the university sponsors clinical trials that aim to enhance medical knowledge and improve patient outcomes. With a diverse team of researchers and healthcare professionals, Istanbul University fosters collaboration across disciplines to explore new therapeutic interventions and contribute to global health advancements. Its robust infrastructure and ethical standards ensure the highest quality in clinical trial management, making it a key player in the field of medical research.

Locations

Istanbul, Buyukcekmece, Turkey

Patients applied

0 patients applied

Trial Officials

TUGBA CIVI KARAASLAN, MSc

Principal Investigator

Research Assistant

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials